VHL-4 is a high-affinity peptidomimetic ligand that selectively binds the VHL E3 ubiquitin ligase complex, serving as an essential building block for PROTAC design and targeted protein degradation. Research-grade purity enables advanced therapeutic development in oncology and drug discovery.
Usually ships within 24 hours.